Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
08/2003
08/21/2003US20030157620 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157619 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157618 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157617 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157616 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157614 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157613 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157612 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157611 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157610 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157609 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157608 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157607 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157606 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157605 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157604 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157603 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157602 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157601 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157583 Methods for determining squalene synthase activity
08/21/2003US20030157547 Combining mixture of RNA polymerase and reversible inhibitor of RNA polymerase (reversible inhibitor does not hybridize to a target nucleic acid sequence), with sample suspected to contain target nucleic acid, exposing to amplification
08/21/2003US20030157543 Methods for identifying genomic deletions
08/21/2003US20030157508 Genetic engineering; gene therapy
08/21/2003US20030157487 Nucleic acid ligands
08/21/2003US20030157103 Human amine transporter antibodies
08/21/2003US20030157099 Human trk receptors and neurotrophic factor inhibitors
08/21/2003DE20308345U1 Injection solution, for use in pyrosequencing equipment, comprises a buffer, deoxynucleotide and an alkaline pH which permits longer sequencing
08/21/2003CA2476468A1 Protein carrier system for therapeutic oligonucleotides
08/21/2003CA2475373A1 Oligonucleotide analogues and methods of use for modulating gene expression
08/20/2003EP0843684B1 Universal solid supports and methods for their use
08/20/2003EP0832298B1 Detecting genetic predisposition for osteoporosis
08/20/2003EP0672067B1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
08/20/2003EP0324789B1 Methods of regulating metabolic stability of proteins
08/20/2003CN1436848A Plant phosphorus hunger inducing transcription factor OsPTF1
08/20/2003CN1436790A Fowl castration vaccine gene and recombinant gene vector
08/20/2003CN1436789A livestock castration vaccine gene and recombinant gene vector
08/20/2003CN1436788A Universal farm animal castration vaccine gene and recombinant gene vector
08/20/2003CN1118573C Non-splicing variants of gp 350/220
08/19/2003US6608213 Fluorescence-labeled probe for DNA and a fluorescence-labeled plasmid
08/19/2003US6608191 Antisense oligonucleotide of given sequence; capable of inhibiting the function of viral RNA
08/19/2003US6608188 Of given nucleotide sequence; useful in developing a method for detecting telomerase activity and diagnosing cancer
08/19/2003US6608186 Pyranosyl nucleic acid conjugates
08/19/2003US6608182 Human vascular endothelial growth factor 2
08/19/2003US6608036 Oligonucleotide N3′→P5′ thiophosphoramidates: their synthesis and administration to treat neoplasms
08/19/2003US6608035 Orally administering to mammal oligonucleotide of 15 to 30 nucleotides, comprising phosphorothioate linkages between nucleosides and 2'-O-alkoxyalkyl-ribonucleotides at each end, whereby oligonucleotide is intact in liver and kidney tissue
08/19/2003US6607902 Cell-wall degrading enzyme variants
08/19/2003US6607888 Method for analyzing nucleic acid reactions
08/19/2003CA2201595C Compositions and methods for the simultaneous detection and quantification of multiple specific nucleic acid sequences
08/19/2003CA2142819C Glucagon receptors
08/19/2003CA2132874C Methods of detecting mammalian nucleic acids isolated from stool specimen and reagents therefor
08/19/2003CA2012414C Hog cholera virus vaccine and diagnostic
08/14/2003WO2003067209A2 Ligands to enhance cellular uptake of biomolecules
08/14/2003WO2003066880A2 Method for accessing microbial diversity
08/14/2003WO2003066878A2 Nucleic acid analysis using layered expression scanning
08/14/2003WO2003066877A2 Compositions and methods relating to hepatic specific genes and proteins
08/14/2003WO2003066818A2 Secretion, transcription and sporulation genes in bacillus clausii
08/14/2003WO2003066812A2 Substituted 4,4-difluoro-4-bora-3a, 4a-diaza-s-indacene compounds for 8-color dna sequencing
08/14/2003WO2003066808A2 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
08/14/2003WO2003066663A2 Peptides for recognition and targeting of glial cell tumors
08/14/2003WO2003066651A1 Methods for separating oligonucleotides
08/14/2003WO2003066650A2 Short interfering rna molecules directed towards a tissue factor coding nucleic acid
08/14/2003WO2003066649A1 Immunostimulatory, covalently lipidated oligonucleotides
08/14/2003WO2003066645A2 Base-labeled nucleosides and nucleotides
08/14/2003WO2003031568A8 Intracellular signaling molecules
08/14/2003WO2003012051A8 Inhibitor of dna methylation
08/14/2003WO2002055735A3 Compositions and methods relating to prostate specific genes and proteins
08/14/2003WO2002044427A3 Cell based triple readout assay systems for identifying compounds that effect transcription
08/14/2003WO2002029117A3 Methods and probes for detection and/or quantification of nucleic acid sequences
08/14/2003WO2002018660A3 Detection of varicella-zoster virus
08/14/2003WO2002008288A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003WO2001098539A3 Gene markers for lung cancer
08/14/2003WO2001090115A3 Haplotypes of the cdk4 gene
08/14/2003US20030153743 Processes for the synthesis of oligomeric compounds
08/14/2003US20030153742 Mixing with nonionic surfactants to form imine linkages with contaminants in solvent
08/14/2003US20030153741 Methods for separating oligonucleotides
08/14/2003US20030153737 Such as 5-O-4,4'dimethoxytrityl-1,2-dideoxy-1-(o-nitrobenzyl)-D-ribofuranose-3-O-(2 -cyanoethyl-N,N'-diisopropyl) phosphoramidite for enhancing cellular uptake, lipophilicity, and retention of oligonucleotides within; antisense therapy
08/14/2003US20030153524 Including extracellular matrix production and/or deposition, neovascularization, inflammation, cell proliferation, cell migration, associated with connective tissue growth factor by administering agent that decreases expression of the factor
08/14/2003US20030153521 Nucleic acid treatment of diseases or conditions related to levels of Ras
08/14/2003US20030153519 Drug delivering a nucleic acid and an RNase inhibitor to a target cell of a vascularized multi-cellular organism; RNA interference
08/14/2003US20030153037 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153036 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153034 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153033 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030153015 Compositions and methods for the treatment of immune related diseases
08/14/2003US20030153000 Genetic engineering; culture product; recovering
08/14/2003US20030152999 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030152995 Electron induced fluorescent method for nucleic acid sequencing
08/14/2003US20030152982 Method for the detection of the antibiotic resistance spectrum of Mycobacterium species
08/14/2003US20030152974 Isolation of nucleic acids on surfaces
08/14/2003US20030152958 Nucleic acid fragment-fixed electrode and its use
08/14/2003US20030152947 Methods for detecting and treating the early onset of aging-related conditions
08/14/2003US20030152924 Detecting single nucleotide polymorphisms via incubating with probes (hairpin motifs)
08/14/2003US20030152922 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030152579 Controlling biosynthesis of hybrid protein; therapy against Helicobacter infections
08/14/2003US20030152526 Bovine milk growth factor
08/14/2003US20030152514 Methods for using anti-MUC18 antibodies
08/14/2003US20030150723 Electrodes linked via conductive oligomers to nucleic acids
08/14/2003CA2475447A1 Short interfering rna molecules directed towards a tissue factor coding nucleic acid
08/14/2003CA2474709A1 Immunostimulatory, covalently lipidated oligonucleotides
08/14/2003CA2474244A1 Methods for separating oligonucleotides
1 ... 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 ... 899